{"ALB": {"Ticker": "ALB", "Company": "Albemarle Corporation", "Sector": "Materials", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Underperform", "Target_Change": "$200 to $240"}, {"Date": "2023-01-26", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$310"}, {"Date": "2023-01-04", "Rating": "Upgrade", "Organization": "Vertical Research", "Rating_Change": "Hold to Buy", "Target_Change": "$275"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Credit Suisse", "Piper Sandler", "Vertical Research"], "Price_Target": 275.0}, "ABC": {"Ticker": "ABC", "Company": "AmerisourceBergen", "Sector": "Health Care", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Resumed", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$185"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Evercore ISI"], "Price_Target": 185.0}, "BAC": {"Ticker": "BAC", "Company": "Bank of America", "Sector": "Financials", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$40"}, {"Date": "2023-01-17", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$36 to $33"}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$38.44"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$45 to $36"}, {"Date": "2022-12-08", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$36"}, {"Date": "2022-11-14", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$40"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Atlantic Equities", "Odeon", "Piper Sandler", "Citigroup", "Deutsche Bank"], "Price_Target": 37.0}, "CHTR": {"Ticker": "CHTR", "Company": "Charter Communications", "Sector": "Communication Services", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$460 to $440"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$380 to $550"}, {"Date": "2022-12-23", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$370 to $340"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wells Fargo", "Truist", "RBC Capital Mkts"], "Price_Target": 443.33}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Underperform", "Target_Change": "$95 to $66"}, {"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$95 to $80"}, {"Date": "2022-12-06", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$95 to $75"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Piper Sandler", "Stifel", "Bernstein"], "Price_Target": 73.67}, "FLT": {"Ticker": "FLT", "Company": "Fleetcor", "Sector": "Information Technology", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$208 to $240"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities"], "Price_Target": 240.0}, "FTNT": {"Ticker": "FTNT", "Company": "Fortinet", "Sector": "Information Technology", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Reiterated", "Organization": "MKM Partners", "Rating_Change": "Buy", "Target_Change": "$70 to $65"}, {"Date": "2023-01-27", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$60"}, {"Date": "2023-01-24", "Rating": "Initiated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$69"}, {"Date": "2023-01-24", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2023-01-18", "Rating": "Initiated", "Organization": "Scotiabank", "Rating_Change": "Sector Outperform", "Target_Change": "$65"}, {"Date": "2023-01-13", "Rating": "Downgrade", "Organization": "BTIG Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["MKM Partners", "Scotiabank", "BTIG Research", "Mizuho", "JP Morgan", "Guggenheim"], "Price_Target": 64.75}, "FOXA": {"Ticker": "FOXA", "Company": "Fox Corporation (Class A)", "Sector": "Communication Services", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$37"}, {"Date": "2023-01-25", "Rating": "Upgrade", "Organization": "Loop Capital", "Rating_Change": "Hold to Buy", "Target_Change": "$40"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$28"}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wolfe Research", "Loop Capital", "Morgan Stanley"], "Price_Target": 35.0}, "INCY": {"Ticker": "INCY", "Company": "Incyte", "Sector": "Health Care", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$100"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Piper Sandler"], "Price_Target": 100.0}, "LYB": {"Ticker": "LYB", "Company": "LyondellBasell", "Sector": "Materials", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Upgrade", "Organization": "Atlantic Equities", "Rating_Change": "Neutral to Overweight", "Target_Change": "$110"}, {"Date": "2022-11-15", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$88"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Atlantic Equities", "Mizuho"], "Price_Target": 99.0}, "TFC": {"Ticker": "TFC", "Company": "Truist Financial", "Sector": "Financials", "Updated": "2023-01-31", "Rating": [{"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Stephens", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$53"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$48"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$61 to $48"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank", "Stephens"], "Price_Target": 49.67}}